登录 | 注册    关注公众号  
微信公众号
搜索
 > 【FAP】

FAP信息

英文名称:Prolyl endopeptidase FAP
中文名称:成纤维细胞激活蛋白α
靶点别称:Post-Proline Cleaving Enzyme,FAPalpha,SIMP,Fibroblast Activation Protein, Alpha,Serine Integral Membrane Protease,Prolyl Endopeptidase FAP,EC 3.4.21.26,EC 3.4.14.5,EC 3.4.21.-,DPPIV,FAPA,170 kDa melanoma membrane-bound gelatinase,Seprase,Gelatine degradation protease FAP,Dipeptidyl peptidase FAP,Fibroblast activation protein alpha,APCE,Integral membrane serine protease,Surface-expressed protease,FAP
上市药物数量:0
临床药物数量:26
最高研发阶段:临床二期

FAP分子别名

FAP,FAPalpha,SIMP,Seprase,APCE

FAP分子背景

FAP (also known as seprase) is a Type II transmembrane serine protease. Both plasma membrane and soluble forms exhibit post-proline cleaving endopeptidase activity, with a marked preference for Ala/Ser-Gly-Pro-Ser/Asn/Ala consensus sequences. Degrade also gelatin, heat-denatured type I collagen. Also has dipeptidyl peptidase activity, with a preference for Ala-Pro, Ile-Pro, Gly-Pro, Arg-Pro and Pro-Pro. The plasma membrane form, in association with either DPP4, PLAUR or integrins, is involved in the pericellular proteolysis of the extracellular matrix (ECM), and hence promotes cell adhesion, migration and invasion through the ECM. Promotes glioma cell invasion through the brain parenchyma by degrading the proteoglycan brevican. Acts as a tumor suppressor in melanocytic cells through regulation of cell proliferation and survival in a serine protease activity-independent manner.

FAP临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定